Skip to content
Trial Eligibility
Menu

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

NCT07227831

This study is recruiting at 8 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced or metastatic HR positive, HER2 negative breast cancer who have progressed on standard of care options can affect patients survival. The main questions it aims to answer are: will the TheraBionic P1 device affect progression free and overall survival in advanced or metastatic HR positive, HER2 negative breast cancer the long term safety and tolerability of the TheraBionic P1 device assessment of how the disease responded to the TheraBionic P1 device

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • HER2-negative Breast Cancer
  • Hormone Receptor Positive Tumor
  • Advanced Breast Cancer
  • Metastatic Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Barbara Ann Karmanos Cancer Institute
Last updated on ClinicalTrials.gov
August 26, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Michigan · 8

  • Karmanos Cancer Institute at McLaren Bay Region · Bay City, MI
  • Karmanos Cancer Institute at McLaren Clarkston · Clarkston, MI
  • Karmanos Cancer Institute · Detroit, MI
  • Karmanos Cancer Institute at McLaren Flint · Flint, MI
  • Karmanos Cancer Institute at McLaren Lapeer Region · Lapeer, MI
  • Karmanos Cancer Institute at McLaren Macomb · Mount Clemens, MI
  • Karmanos Cancer Institute at McLaren Northern · Petoskey, MI
  • Karmanos Cancer Institute at McLaren Port Huron · Port Huron, MI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.